Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr

Published on Mon, May 16, 2011 at 12:00 |  Source : Moneycontrol.com

Updated at Mon, May 16, 2011 at 12:05  

1137 Investors following Plethico Pharma. Share this News with them.
0
0
Share on Tumblr
Plethico Pharma Q4 cons PAT down 23% at Rs 55 cr

ALSO READ

Plethico Pharma has announced its fourth quarter results. The company's Q4FY11 consolidated revenues were up 5.4% at Rs 354 crore versus Rs 336 crore.

Its PAT was down 23% at Rs 55 crore versus Rs 71 crore.

Its EBITDA margin at 20.1% versus 21.7%.

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!